Sysmex Corporation (Kobe, Japan) announced it has obtained the first marketing approval in Japan for an in vitro diagnostic medical device, a testing kit for the novel coronavirus (2019-nCoV Fluorescence Detection Real-Time RT-PCR Kit). The company subsequently filed a change request, which was approved June 2, additionally including saliva as a sample type. The company says … [Read more...]